可吸收局部止血劑市場：規模、細分市場、份額、法規、報銷、程序和 2033 年預測

可吸收局部止血劑經常用於創傷、燒傷和外科手術中控制出血並實現止血。 外科手術範圍從心血管、胃腸、產科、婦科到骨科和周邊神經手術等其他類型的手術。

可吸收外用止血材料，又稱被動止血材料（膠原蛋白、明膠、多醣、氧化再生纖維素、組合止血材料），是吸收性海綿、泡沫、墊片、外用止血材料等材料。它應用於出血部位。 理想的局部止血劑的確切特徵因外科專業、特定患者群體、手術要求、出血類型和藥物的具體作用機製而異。

本報告深入探討了全球可吸收局部止血劑市場，包括競爭格局、SWOT 分析、到 2033 年的市場預測、COVID-19 的影響、區域和國家趨勢等。

目錄

目前市面上可吸收局部止血材料及競爭狀況

• 對主要產業趨勢的見解
• 2015 年至 2033 年可吸收外用止血材料按細分市場劃分的市場總收入及市場前景
• 有關數量、平均售價和市場價值的詳細數據

全球、區域與國家見解

• 可吸收外用止血劑市場的SWOT分析
• 可吸收外用止血材料市場的競爭動態洞察與趨勢
• 各國醫療保健系統概覽
• 按國家/地區劃分的報銷政策
• 各國醫療科技的監管狀況

Abstract

Topical Absorbable Hemostats Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Wound Care Management therapeutic area.

The model discusses in detail the impact of COVID-19 on Topical Absorbable Hemostats market for the year 2020 and beyond. Topical hemostatic agents are frequently used in efforts to control bleeding and achieve hemostasis in trauma settings, burn cases and surgical procedures. Surgical procedures vary from cardiovascular, gastrointestinal, obstetrics, and gynecological to other types of surgeries such as orthopedic and peripheral nerve operations.

Topical Absorbable Hemostatic agents, also known as passive hemostats (collagen, gelatin, polysaccharide, oxidized regenerated cellulose and combination hemostats), consist of the integration of an absorbable sponge, foam, pad, or other material with a topical hemostatic agent, which is then applied to the bleeding site. The exact properties of the ideal topical hemostatic agent will vary depending on the surgical specialty, the specific patient population, procedure requirements, the type of bleeding, and the agent's specific mechanism of action.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Topical Absorbable Hemostats and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Topical Absorbable Hemostats market revenue by segment and market outlooks from 2015-2033.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Topical Absorbable Hemostats market.
• Competitive dynamics insights and trends provided for Topical Absorbable Hemostats market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Ethicon Inc, CR Bard Inc, Pfizer Inc, B. Braun Melsungen AG, Teleflex Inc, Medtronic Plc, Gelita Medical GmbH, Meril Life Sciences Pvt Ltd and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Topical Absorbable Hemostats marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Topical Absorbable Hemostats market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Topical Absorbable Hemostats market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Topical Absorbable Hemostats market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Topical Absorbable Hemostats market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.